Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
S&P Global heads into its October 27 earnings with a notable gap between where the stock trades and where analysts think it belongs, and that gap just got a little more interesting.
Morgan Stanley's Toni Kaplan cut the price target on SPGI to $477 from $525 this week, while keeping an Overweight rating. That move lands right as the stock has fallen roughly 11% over the past month to $396.13, even as it clawed back about 1% on the week. Mizuho trimmed its target the same day, to $531 from $554, also holding its Outperform rating. The pattern is consistent: analysts remain constructive on direction but are pulling their numbers down to meet a softer near-term reality. The consensus mean target is $518, implying about 31% upside from current levels, a gap wide enough to be worth interrogating rather than simply accepting.
The bull case rests on durable structural tailwinds. An estimated $11 trillion refinancing wall over the next four-plus years supports the Ratings business. The Indices franchise benefits from passive investing flows and AI-related capital expenditure themes. Over 500 MCP customers were on the platform in Q2, and management has guided toward returning 85% or more of free cash flow to shareholders in 2027. The bear case is less about the franchise quality and more about near-term execution. Market Intelligence growth has been squeezed by elongated sales cycles, particularly with large clients renegotiating AI data rights. Sustainability budgets were cut more sharply than expected in Q2. Energy revenue grew only around 3% in Q2 as geopolitical disruption weighed on customer activity. The Mobility spin-off adds a further layer of uncertainty for investors trying to model the go-forward earnings base. On valuation, the stock trades at roughly 20 times trailing earnings, with the P/E multiple compressing by about 2.6 turns over the past month, a meaningful re-rating even as the absolute level remains elevated.
Short interest is not a meaningful part of this story. At 2.1% of the free float, it has been falling steadily, down 22% over the past month and another 2.6% on the week. The lending market reflects that indifference: availability is exceptionally loose at roughly 9,374%, meaning shares are freely available to borrow relative to the existing short position. Borrow cost has ticked up about 49% on the week to 0.41%, but that is noise given the absolute level remains near-zero. The ORTEX short score has drifted lower to 32.9, consistent with a modest and diminishing short position. Options positioning tells a more cautious story. The put/call ratio is running at 1.44, above its 20-day average of 1.33 and about one standard deviation elevated. That is not an extreme reading, but it does suggest more hedging activity heading into the print than was present a month ago, when the ratio was running closer to 1.15.
The most striking insider signal in the data is from five months ago. In late April and early May, three senior insiders made open-market purchases at prices around $429 to $431. CEO Martina Cheung bought nearly $1 million worth, the CEO of S&P Dow Jones Indices Catherine Clay bought $1.08 million, and director Robert Moritz added $500,000. None of these were under 10b5-1 plans. The stock is now trading roughly 8% below those purchase prices, which gives that cluster of buying some additional context as the October 27 print approaches. More recent insider activity has been limited to routine stock-award transactions with no discretionary buying signal.
Among close peers, MORN rose 5% on the week and FDS added 4.6%, while the most correlated peer MCO slipped 0.5%. SPGI's 1% weekly gain trails much of the group, consistent with the stock's role as an underperformer on a longer-term basis. Wikipedia page traffic is running about 1.4 standard deviations above its trailing 90-day average, reflecting elevated retail attention, though that dataset has not been measured to lead the company's reported figures.
With earnings due in 20 days, the focus will be on whether management can demonstrate stabilisation in Market Intelligence sales cycles, whether Energy re-accelerates in the second half as guided, and whether the Mobility separation timetable and terms provide enough clarity to remove that overhang from the valuation debate.
See the live data behind this article on ORTEX.
Open SPGI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
